DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer Article

Kurani, Hetakshi, Razavipour, Seyedeh Fatemeh, Harikumar, Kuzhuvelil B et al. (2022). DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer . CLINICAL CANCER RESEARCH, 28(9), 1948-1965. 10.1158/1078-0432.CCR-21-1299

Open Access International Collaboration

cited authors

  • Kurani, Hetakshi; Razavipour, Seyedeh Fatemeh; Harikumar, Kuzhuvelil B; Dunworth, Matthew; Ewald, Andrew J; Nasir, Apsra; Pearson, Gray; Van Booven, Derek; Zhou, Zhiqun; Azzam, Diana; Wahlestedt, Claes; Slingerland, Joyce

sustainable development goals

authors

publication date

  • May 1, 2022

published in

keywords

  • ACTIVATION
  • ALDEHYDE DEHYDROGENASE
  • CYCLE PROGRESSION
  • GENE-EXPRESSION
  • GROWTH
  • H3K79 METHYLATION
  • INHIBITION
  • Life Sciences & Biomedicine
  • METHYLTRANSFERASES
  • MYC
  • Oncology
  • Science & Technology
  • TRANSCRIPTION FACTOR

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 1948

end page

  • 1965

volume

  • 28

issue

  • 9